MedTrace Logo

Quality of Life in Patients Undergoing Total Pelvic Exenteration

NCT00597805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2024-12-18

No results posted yet for this study

Summary

The purpose of this study is to learn more about the personal experiences of patients who are treated with pelvic exenteration surgery. Pelvic exenteration is a surgical procedure in which the pelvic organs including the reproductive organs, bladder and/or rectum are removed. We would like to understand more about the physical, emotional, educational, and sexual needs of patients who are treated with this surgery. We will use what we learn from this study to help find better ways of preparing patients for this type of surgery. This will also allow us to be more helpful to patients' needs after surgery.

Conditions

  • Total Exenteration
  • Anterior or Posterior Pelvic Exenteration
  • Gynecologic Malignancies
  • Colorectal Malignancies
  • Urologic Malignancies

Interventions

BEHAVIORAL

questionnaires/interviews

All patients who agree to participate will be interviewed for a baseline quality of life assessment prior to surgery. A brief in hospital interview will follow in the peri-operative period. In the ensuing months, patients will be interviewed at approximately 3, 6 and 12 months post-operatively (eg: 3 month interview will be done between 8-16 weeks and 6 month interview between 20-28 months post-operatively). Annual interviews in years two through five will be employed to determine areas for future study and solicit narrative on transition toward cancer survivorship.

Sponsors & Collaborators

Principal Investigators

  • Dennis Chi, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2024-12-12
Completion
2024-12-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00597805 on ClinicalTrials.gov